📈 நேரலை சந்தை கண்காணிப்பு

NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.

நேரலை இன்று 763 பகுப்பாய்வு செய்யப்பட்டது
பின்தொடர்Telegram
763
இன்று
169,464
இதுவரை பகுப்பாய்வு செய்யப்பட்டவை
50,094
நேர்மறை
8,647
எதிர்மறை
100,887
நடுநிலை
9,768
கண்காணி
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
அழி
1,000+ அறிவிப்புகள் பொருந்தும் தாக்கம் 5+ Symbol: M
நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

Milky Mist Q2 FY27 Call: Yogurt Revenue Up 168% YoY, Rs 40 Cr Capex Expands Capacity to 150 TPD

Milky Mist Dairy Food Limited released its Q2 FY27 earnings call transcript, highlighting strong operational performance across key value-added dairy segments. The yogurt category grew 168% YoY, supported by a newly commissioned Rs 40 crore Greek yogurt facility at Perundurai expanding capacity from 20 tons/day to 150 tons/day. Paneer, cheese, and curd grew by 44%, 31%, and 22% YoY, respectively, while online channels expanded to contribute 21% of total revenue in H1 FY27 versus 11% in H1 FY26. Management noted the protein portfolio now contributes 12% to 13% of top-line sales with healthy margins.

நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

Advit Jewels Q2 FY27 Earnings Call: H1 PAT Up 31.7% to ₹20.95 Cr; Expanding Retail Presence

Advit Jewels Limited (Rambhajo) released the transcript of its Q2 FY27 earnings conference call. For H1 FY27, revenue reached ₹94.5 crore, up 28.6% YoY, while net profit grew 31.7% YoY to ₹20.95 crore with a 22.2% net profit margin. In Q2 FY27 alone, revenue grew 23.9% YoY to ₹59.1 crore with EBITDA of ₹16.4 crore. The company outlined retail expansion plans, including a 35,000 sq ft flagship B2C store in Jaipur and a new Defence Colony showroom in Delhi targeted for Q4 FY27 to expand beyond Rajasthan.

எதிர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

Greenlam Q2 FY27 Consolidated Revenue Up 8.3% to ₹875.18 Cr; PAT Falls 23% to ₹24.48 Cr

Greenlam Industries reported consolidated revenue of ₹875.18 crore for Q2 ended September 30, 2026, an 8.3% increase compared to ₹808.26 crore in the same period last year. However, consolidated profit after tax declined 22.9% YoY to ₹24.48 crore from ₹31.77 crore, impacted by higher operational expenses. On a standalone basis, revenue stood at ₹668.70 crore with net profit dropping 17.2% YoY to ₹38.00 crore. Half-year consolidated revenue reached ₹1,671.88 crore, while PAT for H1 stood at ₹45.72 crore.

நேர்மறை தாக்கம் 9/10 நிதி முடிவுகள்

Q2 FY27 PAT Jumps 93% to ₹32 Cr; Order Book Surges to ₹3,514 Cr

Marine Electricals reported strong Q2 FY27 results, with revenue growing 82% YoY to ₹405 crore and PAT surging 93% YoY to ₹32 crore. The company secured new orders worth ₹2,059 crore during Q2 FY27 alone, lifting its total open order book to ₹3,514 crore (up 386% YoY), which equals ~3.6x its TTM revenue of ₹968 crore. Growth was primarily led by the Industrial division, where Q2 revenue grew 164% supported by data center and semiconductor demand. Additionally, it commissioned its sixth manufacturing facility in Goa, which is expected to triple overall manufacturing capacity.

நேர்மறை தாக்கம் 7/10 மற்றவை

Lokesh Machines Wins Rs 19.89 Cr Order from Cummins India for Special Milling & Boring Machines

Lokesh Machines Limited has secured a domestic supply order valued at Rs 19.89 crore (net of taxes) from Cummins India Limited, Pune. The contract covers the supply of Special Finish Milling and Finish Boring Machines. Compared to recent quarterly revenues of approximately Rs 50-51 crore (Sep and Dec 2025 quarters), this single order represents nearly 39% of a quarterly top-line run rate. The transaction is not a related-party transaction and promoters hold no interest in Cummins India.

📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்

நேர்மறைஎதிர்மறைநடுநிலைகவனம்
நேர்மறை தாக்கம் 5/10 வழக்கமானது

Innomet Secures ₹1.13 Cr Order from Federal-Mogul Goetze for Copper-Infiltrant

Innomet Advanced Materials Limited has received a purchase order from Federal-Mogul Goetze (India) Ltd. on November 5, 2026. The total purchase order value stands at ₹1,13,13,132 (including packing charges and IGST), with a basic taxable value of ₹95,57,400. The order is for the supply of 'COPPER -INFILTRANT IPL96' in the ordinary course of business. Delivery is scheduled as per the purchase order terms, with no promoter interest or related-party involvement.

நேர்மறை தாக்கம் 5/10 விரிவாக்கம்

Motherson to Set Up Facility in Paraguay; Acquires SPV for ~EUR 10M Capitalization

Samvardhana Motherson International Limited has approved establishing a new wiring harness manufacturing facility in Paraguay via the 100% acquisition of a special purpose vehicle, Golden Bridge Sociedad Anónima. The acquisition price is nominal at USD 1 plus ~USD 8,000 in legal fees, with planned capitalization in tranches of PYG 68,430 million (approx. EUR 10 million). The target will operate under the PKC Group division at Guarambaré to support regional growth in South America. The transaction is slated for completion in Q3 FY2026-27.

நடுநிலை தாக்கம் 5/10 நிதி முடிவுகள்

VTM Limited Reports Q2 Results with Unmodified Auditor Opinion for Quarter Ended Sep 30, 2026

VTM Limited has submitted its unaudited standalone financial results for the quarter and half-year ended September 30, 2026. The company reported that the statutory auditors, M/s. CNGSN & Associates LLP, issued an unmodified limited review report. The board meeting commenced at 10:45 AM and concluded at 02:35 PM on November 5, 2026. Detailed financial numbers in the filing extract are partially truncated, but standard quarterly disclosure obligations have been completed.

நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

Akums Q2 FY27 Earnings Call: Revenue Up 31.9% YoY to Rs 1,342 Cr, PAT Surges 168%

Akums Drugs and Pharmaceuticals released its Q2 FY27 earnings conference call transcript, detailing strong quarterly operational performance. Consolidated revenue rose 31.9% YoY to Rs 1,342 crore, while EBITDA surged 106% YoY to Rs 195 crore with margins expanding to 14.5% (up from 9.3% in Q2 FY26). Profit after tax grew 168.3% YoY to Rs 115 crore, led by a 38.6% YoY growth in its core CDMO revenue (Rs 1,115 crore). Management also announced plans for a new oral solids facility in Baddi with an annual capacity of over 6 billion units, targeted to operationalize by Q1 FY28.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Motherson Q2 FY27: Revenue Up 27% to ₹38,280 Cr, Normalized PAT Up 37% to ₹1,175 Cr

Samvardhana Motherson reported a strong performance for Q2 FY27, with consolidated revenue rising 27% YoY to ₹38,280 crore, driven by integration of acquisitions (Autoelectric and Yutaka Giken) and strength in wiring harnesses. Consolidated EBITDA grew 23% YoY to ₹3,353 crore, while Normalized PAT (Concern Share) increased 37% YoY to ₹1,175 crore. The company maintained a conservative balance sheet with a Net Leverage Ratio of 0.8x and liquidity of ₹17,474 crore against gross debt of ₹19,355 crore. Additionally, its booked business reached an all-time high of USD 106 billion (excluding Consumer Electronics), supported by ongoing capacity expansions and a new acquisition in aerospace/defense connectors.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Q2FY27 Revenue Jumps 27% YoY to Rs 38,280 Cr; Booked Business Hits Record $106 Bn

Samvardhana Motherson reported its highest-ever quarterly revenue of Rs 38,280 crore for Q2FY27, up 27% YoY, and H1FY27 revenue of Rs 73,524 crore (+22% YoY). Consolidated EBITDA for the quarter stood at Rs 3,353 crore with Normalized PAT at Rs 1,175 crore. The company's total booked business reached an all-time high of USD 106 billion, up from USD 87.2 billion reported previously. The balance sheet remained comfortable with a leverage ratio of 0.8x against a policy cap of 2.5x, while H1 capex totaled Rs 3,585 crore out of a planned full-year outlay of Rs 6,000 crore (+/- 10%).

நடுநிலை தாக்கம் 6/10 நிதி முடிவுகள்

Motherson Reports Q2 FY27 Results; Approves Conversion of ₹1,450.10 Cr CCDs

Samvardhana Motherson International announced its unaudited financial results for Q2 and H1 ended September 30, 2026. Subsequent to the quarter on October 8, 2026, the company allotted 10,32,09,960 equity shares of ₹1 each at a premium of ₹139.50 upon conversion of ₹1,450.10 crore Compulsorily Convertible Debentures (CCDs). Additionally, the NCLAT approved a Scheme of Arrangement on October 26, 2026, amalgamating three group entities, which impacts standalone statements but has no effect on consolidated financials.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Cemindia Q2 FY27: Order Book Hits Record ₹32,715 Cr; Q2 PAT Up 21% to ₹131 Cr

Cemindia Projects Limited (formerly ITD Cementation) released its Q2/H1 FY27 investor presentation, reporting a 25% YoY increase in Q2 revenue to ₹2,749 Cr and a 21% YoY rise in PAT to ₹131 Cr. The order book reached an all-time high of ₹32,715 Cr (approx. 3.2x TTM revenue of ₹10,184 Cr), supported by ₹12,005 Cr of new orders secured in H1 FY27. Additionally, the company highlighted a successful ₹1,400 Cr QIP (~2.3x subscribed) and credit rating upgrades to AA/AA- in October 2026. Net debt stood at ₹773 Cr against a net worth of ₹2,619 Cr as of September 30, 2026.

நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

Polymed H1 FY27 Revenue Up 30.6% to Rs 1,105.9 Cr; Non-Infusion Mix Expands to 51%

Poly Medicure released its Q2/H1 FY27 investor presentation, reporting consolidated operating revenue of Rs 1,105.9 Cr for H1 FY27, up 30.6% YoY (14.4% organic growth). Total operating revenue for Q2 FY27 stood at Rs 580.5 Cr compared to Rs 443.9 Cr in Q2 FY26. Segments beyond core infusion therapy expanded to drive 51% of total revenue in H1 FY27, led by strong growth in Cardiology (Rs 55.6 Cr) and Orthopaedics (Rs 91.9 Cr). The company maintains a strong liquidity position with cash and equivalents of Rs 839.1 Cr as of September 30, 2026.

நேர்மறை தாக்கம் 6/10 நிதி முடிவுகள்

GKW Limited Q2 FY27 PAT at Rs 3.93 Cr vs Loss of Rs 15.59 Cr YoY; Revenue Drops 35%

GKW Limited reported its Q2 FY27 (quarter ended September 30, 2026) results with revenue from operations declining 34.6% YoY to Rs 7.11 Cr compared to Rs 10.87 Cr in Q2 FY26. Despite lower revenues, net profit turned positive to Rs 3.93 Cr from a net loss of Rs 15.59 Cr in Q2 FY26, primarily due to lower other expenses (Rs 5.65 Cr vs Rs 23.07 Cr). Total Comprehensive Income stood at Rs 64.37 Cr, boosted by a Rs 60.56 Cr gain in Other Comprehensive Income from equity instruments. The company continues to contest a stamp duty demand of Rs 32.56 Cr in appeal, with the order currently awaited.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Uno Minda Q2 FY27 Consolidated Revenue Up 38% to Rs 6,655 Cr; Announces Rs 1,415 Cr Expansions

Uno Minda released its Q2 FY27 investor presentation, reporting consolidated revenue growth of 38% YoY to Rs 6,655 Cr and PAT (UML share ex-exceptional) up 38% YoY to Rs 420 Cr. EBITDA expanded 33% YoY to Rs 733 Cr with an 11.0% margin. The company detailed four strategic expansion projects totaling Rs 1,415 Cr (~6.8% of TTM revenue), including a greenfield aluminum casting plant at Hosur (Rs 510 Cr) and a new TGSIN plant (Rs 670 Cr). Green mobility systems saw rapid growth, rising 53% YoY to Rs 291 Cr.

எதிர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Thirumalai Chemicals Q2 FY27 Consolidated Net Loss at ₹34.31 Cr; Net Current Liabilities at ₹772.69 Cr

Thirumalai Chemicals reported a consolidated net loss of ₹34.31 crore for Q2 FY27 (ended September 30, 2026), compared to a loss of ₹43.67 crore in the preceding quarter. Revenue from operations stood at ₹596.47 crore, up from ₹546.67 crore in Q1. Notably, the group faces liquidity pressure, with current liabilities exceeding current assets by ₹772.69 crore, primarily due to capex at its US subsidiary TCL Specialties LLC. To bolster liquidity, the company raised ₹96.73 crore via partial disposal of Ultramarine & Pigments shares and ₹10.38 crore from selling windmills and land.

நேர்மறை தாக்கம் 5/10 மற்றவை

ABS Marine Bags ₹21.94 Cr Charter Party Contract from G R Infraprojects

ABS Marine Services Limited has signed a Time Charter Party Agreement with G R Infraprojects Limited for its Offshore Support Vessel, MV SERENITY. The total contract size is approximately ₹21.94 crore (inclusive of 18% GST), representing about 4.4% of ABS Marine's TTM revenue of ₹499 crore. The charter tenure is 160 days to support pipelay and subsea works in ONGC fields off the west coast of India. Vessel delivery is scheduled between 20 November and 10 December 2026.

நேர்மறை தாக்கம் 8/10 நிதி முடிவுகள்

Uno Minda Q2 FY27 PAT Jumps 38% YoY to ₹420 Cr; Approves ₹85 Cr Sunroof Expansion

Uno Minda reported a strong Q2 FY27 performance with consolidated revenue increasing 38% YoY to ₹6,655 crore, driven by volume growth and value addition across switches, lighting, alloy wheels, and EV systems. Consolidated EBITDA grew 33% YoY to ₹733 crore, while PAT attributable to shareholders rose 38% YoY to ₹420 crore. For H1 FY27, revenue reached ₹12,212 crore (up 32%) and PAT reached ₹716 crore (up 32%). Additionally, the board approved an incremental capex of ₹85 crore to expand its Bawal sunroof plant, slated for commissioning by Q2 FY28.

நேர்மறை தாக்கம் 7/10 நிதி முடிவுகள்

Electronics Mart Q2 FY27: PAT surges 149% to ₹40 Cr, Revenue up 19% to ₹1,900 Cr

Electronics Mart India Limited (EMIL) reported strong operational performance in Q2 FY27 with revenue growing 19.4% YoY to ₹1,899.7 Cr and reported PAT jumping 148.7% YoY to ₹40.2 Cr. Growth was supported by a 16.5% Same Store Sales Growth (SSSG) and an average ticket size increase of 14.6% to ₹25,756. Store-level performance showed wide divergence, with mature stores (>4 years old) delivering an EBITDA margin of 9.7% versus 6.4% for non-mature stores. For H1 FY27, revenue reached ₹4,318.7 Cr (+29.7% YoY) with PAT rising to ₹161 Cr.

⚠️ இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்